Make better development decisions—earlier, faster, and with greater confidence
Model-informed drug development uses modeling and simulation to predict how a drug may perform across doses, populations, and development scenarios. By applying the right quantitative approach at each stage, sponsors can make faster, more confident decisions about dosing, trial design, regulatory strategy, and evidence generation.
Premier Research’s integrated MIDD and regulatory experts help teams reduce development risk, streamline pathways, and maximize the value of existing data across studies and populations.
What’s Inside
- How MIDD can support dose strategy, trial design, regulatory planning, and development efficiency
- Modeling approaches applied across the development lifecycle, from preclinical through Phase 3 and beyond
- Ways MIDD can inform first-in-human dosing, proof-of-mechanism decisions, study design, labeling, and special populations
- The value of an integrated regulatory and MIDD strategy for complex development programs
Download the Factsheet
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.